You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海爾生物(688139.SH):子公司重慶三大偉業增資並引入員工持股平台
格隆匯 07-27 16:24

格隆匯7月27日丨海爾生物(688139.SH)公佈,公司為增強子公司重慶三大偉業製藥有限公司(“重慶三大偉業”)運營能力,激發內生動力與活力,同意重慶三大偉業進行增資並引入員工持股平台。

員工持股平台擬以總額2880萬元人民幣對重慶三大偉業增資並取得其合計4.52%的股權(即重慶三大偉業23.6699萬元註冊資本)。增資完成後,重慶三大偉業註冊資本由500萬元增加至523.6699萬元。

本次關聯交易通過向子公司重慶三大偉業增資,一方面提升了其資本實力,增資款可直接用於重慶三大偉業建設發展,增強其自身運營能力;另一方面員工持股平台的進入,展示了員工對重慶三大偉業發展的信心,也可更好地調動重慶三大偉業經營管理團隊、核心技術人員和核心骨幹員工的積極性,有利於挖掘企業內部成長的原動力,提升治理水平與競爭力,加速公司血液安全生態佈局。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account